| First Author | Petkau G | Year | 2022 |
| Journal | Nat Commun | Volume | 13 |
| Issue | 1 | Pages | 2274 |
| PubMed ID | 35477960 | Mgi Jnum | J:325408 |
| Mgi Id | MGI:7265868 | Doi | 10.1038/s41467-022-29979-x |
| Citation | Petkau G, et al. (2022) The timing of differentiation and potency of CD8 effector function is set by RNA binding proteins. Nat Commun 13(1):2274 |
| abstractText | CD8(+) T cell differentiation into effector cells is initiated early after antigen encounter by signals from the T cell antigen receptor and costimulatory molecules. The molecular mechanisms that establish the timing and rate of differentiation however are not defined. Here we show that the RNA binding proteins (RBP) ZFP36 and ZFP36L1 limit the rate of differentiation of activated naive CD8(+) T cells and the potency of the resulting cytotoxic lymphocytes. The RBP function in an early and short temporal window to enforce dependency on costimulation via CD28 for full T cell activation and effector differentiation by directly binding mRNA of NF-kappaB, Irf8 and Notch1 transcription factors and cytokines, including Il2. Their absence in T cells, or the adoptive transfer of small numbers of CD8(+) T cells lacking the RBP, promotes resilience to influenza A virus infection without immunopathology. These findings highlight ZFP36 and ZFP36L1 as nodes for the integration of the early T cell activation signals controlling the speed and quality of the CD8(+) T cell response. |
